|
PF-60583 |
DOLIFOL 100 mg/mL Solución oral |
2027-01-13 |
|
Alpharma, S. A. De C. V. |
Mexico
|
Befasa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48736 |
REMICITAL 20 mg Tableta recubierta simple |
2029-04-19 |
|
Psicofarma S. A. de C. V. |
Mexico
|
Befasa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-49554 |
SELECTIVE 10 mg Tabletas recubiertas |
2029-05-20 |
|
Neolpharma, S.A. de C.V. |
Mexico
|
Befasa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-42764 |
BROMURO DE IPRATROPIO Y SULFATO DE ALBUTEROL Nephron 0.5 mg/3 mg Solución para inhalación |
2024-04-03 |
|
Nephron Pharmaceuticals Corporation |
Estados Unidos de América
|
Xentury Global, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-42903 |
EPINEFRINA RACEMICA Nephron 2.25% Solución para respirador |
2024-05-07 |
|
Nephron Pharmaceuticals Corporation |
Estados Unidos de América
|
Xentury Global, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-43901 |
EPINEFRINA RACÉMICA Nephron 2.25 % Solución para Inhalación |
2014-11-20 |
|
Nephron Pharmaceuticals Corporation |
Estados Unidos de América
|
Xentury Global, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-56398 |
MAVENCLAD 10 mg Comprimidos |
2024-02-22 |
|
Merck |
Italia
|
Merck |
Resco |
Farma Salud |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48706 |
PLATELET IC 75 mg Comprimido recubierto |
2029-02-22 |
|
Pharmoz |
España
|
Pharmoz |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51850 |
ODDONTOPRILO, Solución inyectable |
2025-09-11 |
|
Latin Farma |
Colombia
|
Farmen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51851 |
ODDONTOLIDO, Solución inyectable |
2025-09-11 |
|
Latin Farma |
Colombia
|
Farmen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|